Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration

T. Nilsson, P. Arkhammar, P. Rorsman, P. O. Berggren

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

The effects of galanin and somatostatin on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using β-cells isolated from obese hyperglycemic mice. Whereas insulin release was measured in a column perifusion system, membrane potential and [Ca2+](i) were measured with the fluorescent indicators bisoxonol (bis-(1,3-diethylthiobarbiturate)trimethineoxonol) and quin 2, in cell suspensions in a cuvette. Galanin (16 nM) and somatostatin (400 nM) suppressed glucose-stimulated insulin release in parallel to promoting repolarization and a reduction in [Ca2+](i). The reduction in [Ca2+](i) comprised an initial nadir followed by a slow rise and the establishment of a new steady state level. The slow rise in [Ca2+](i) was abolished by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. Both peptides suppressed insulin release even when [Ca2+](i) was raised by 25 mM K+. Under these conditions the inhibition of insulin release was partly reversed by an increase in the glucose concentration. Addition of 5 mM Ca2+ to a cell suspension, incubated in the presence of 20 mM glucose and either galanin, somatostatin, or the α2-adrenergic agonist clonidine (10 nM), induced oscillations in [Ca2+](i), this effect disappearing subsequent to the addition of D-600. The effects of galanin, somatostatin, and clonidine on [Ca2+](i) were abolished in β-cells treated with pertussis toxin. In accordance with measurements of [Ca2+](i) treatment with pertussis toxin reversed the inhibitory effect of galanin on insulin release. The inhibitory action of galanin and somatostatin on insulin release is probably accounted for by not only a repolarization-induced reduction in [Ca2+](i) and a decreased sensitivity of the secretory machinery to Ca2+, but also by a direct interaction with the exocytotic process. It is proposed that these effects are mediated by a pertussis toxin-sensitive GTP-binding protein.

Original languageEnglish
Pages (from-to)973-980
Number of pages8
JournalJournal of Biological Chemistry
Volume264
Issue number2
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Galanin
Somatostatin
GTP-Binding Proteins
Insulin
Pertussis Toxin
Gallopamil
Obese Mice
Clonidine
Glucose
Membrane Potentials
Suspensions
Membranes
Adrenergic Agonists
Machinery
Peptides
Electric potential

ASJC Scopus subject areas

  • Biochemistry

Cite this

Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration. / Nilsson, T.; Arkhammar, P.; Rorsman, P.; Berggren, P. O.

In: Journal of Biological Chemistry, Vol. 264, No. 2, 01.01.1989, p. 973-980.

Research output: Contribution to journalArticle

@article{08bd607a0cf542f2833e2e2cdb04881e,
title = "Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration",
abstract = "The effects of galanin and somatostatin on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using β-cells isolated from obese hyperglycemic mice. Whereas insulin release was measured in a column perifusion system, membrane potential and [Ca2+](i) were measured with the fluorescent indicators bisoxonol (bis-(1,3-diethylthiobarbiturate)trimethineoxonol) and quin 2, in cell suspensions in a cuvette. Galanin (16 nM) and somatostatin (400 nM) suppressed glucose-stimulated insulin release in parallel to promoting repolarization and a reduction in [Ca2+](i). The reduction in [Ca2+](i) comprised an initial nadir followed by a slow rise and the establishment of a new steady state level. The slow rise in [Ca2+](i) was abolished by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. Both peptides suppressed insulin release even when [Ca2+](i) was raised by 25 mM K+. Under these conditions the inhibition of insulin release was partly reversed by an increase in the glucose concentration. Addition of 5 mM Ca2+ to a cell suspension, incubated in the presence of 20 mM glucose and either galanin, somatostatin, or the α2-adrenergic agonist clonidine (10 nM), induced oscillations in [Ca2+](i), this effect disappearing subsequent to the addition of D-600. The effects of galanin, somatostatin, and clonidine on [Ca2+](i) were abolished in β-cells treated with pertussis toxin. In accordance with measurements of [Ca2+](i) treatment with pertussis toxin reversed the inhibitory effect of galanin on insulin release. The inhibitory action of galanin and somatostatin on insulin release is probably accounted for by not only a repolarization-induced reduction in [Ca2+](i) and a decreased sensitivity of the secretory machinery to Ca2+, but also by a direct interaction with the exocytotic process. It is proposed that these effects are mediated by a pertussis toxin-sensitive GTP-binding protein.",
author = "T. Nilsson and P. Arkhammar and P. Rorsman and Berggren, {P. O.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "264",
pages = "973--980",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration

AU - Nilsson, T.

AU - Arkhammar, P.

AU - Rorsman, P.

AU - Berggren, P. O.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The effects of galanin and somatostatin on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using β-cells isolated from obese hyperglycemic mice. Whereas insulin release was measured in a column perifusion system, membrane potential and [Ca2+](i) were measured with the fluorescent indicators bisoxonol (bis-(1,3-diethylthiobarbiturate)trimethineoxonol) and quin 2, in cell suspensions in a cuvette. Galanin (16 nM) and somatostatin (400 nM) suppressed glucose-stimulated insulin release in parallel to promoting repolarization and a reduction in [Ca2+](i). The reduction in [Ca2+](i) comprised an initial nadir followed by a slow rise and the establishment of a new steady state level. The slow rise in [Ca2+](i) was abolished by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. Both peptides suppressed insulin release even when [Ca2+](i) was raised by 25 mM K+. Under these conditions the inhibition of insulin release was partly reversed by an increase in the glucose concentration. Addition of 5 mM Ca2+ to a cell suspension, incubated in the presence of 20 mM glucose and either galanin, somatostatin, or the α2-adrenergic agonist clonidine (10 nM), induced oscillations in [Ca2+](i), this effect disappearing subsequent to the addition of D-600. The effects of galanin, somatostatin, and clonidine on [Ca2+](i) were abolished in β-cells treated with pertussis toxin. In accordance with measurements of [Ca2+](i) treatment with pertussis toxin reversed the inhibitory effect of galanin on insulin release. The inhibitory action of galanin and somatostatin on insulin release is probably accounted for by not only a repolarization-induced reduction in [Ca2+](i) and a decreased sensitivity of the secretory machinery to Ca2+, but also by a direct interaction with the exocytotic process. It is proposed that these effects are mediated by a pertussis toxin-sensitive GTP-binding protein.

AB - The effects of galanin and somatostatin on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using β-cells isolated from obese hyperglycemic mice. Whereas insulin release was measured in a column perifusion system, membrane potential and [Ca2+](i) were measured with the fluorescent indicators bisoxonol (bis-(1,3-diethylthiobarbiturate)trimethineoxonol) and quin 2, in cell suspensions in a cuvette. Galanin (16 nM) and somatostatin (400 nM) suppressed glucose-stimulated insulin release in parallel to promoting repolarization and a reduction in [Ca2+](i). The reduction in [Ca2+](i) comprised an initial nadir followed by a slow rise and the establishment of a new steady state level. The slow rise in [Ca2+](i) was abolished by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. Both peptides suppressed insulin release even when [Ca2+](i) was raised by 25 mM K+. Under these conditions the inhibition of insulin release was partly reversed by an increase in the glucose concentration. Addition of 5 mM Ca2+ to a cell suspension, incubated in the presence of 20 mM glucose and either galanin, somatostatin, or the α2-adrenergic agonist clonidine (10 nM), induced oscillations in [Ca2+](i), this effect disappearing subsequent to the addition of D-600. The effects of galanin, somatostatin, and clonidine on [Ca2+](i) were abolished in β-cells treated with pertussis toxin. In accordance with measurements of [Ca2+](i) treatment with pertussis toxin reversed the inhibitory effect of galanin on insulin release. The inhibitory action of galanin and somatostatin on insulin release is probably accounted for by not only a repolarization-induced reduction in [Ca2+](i) and a decreased sensitivity of the secretory machinery to Ca2+, but also by a direct interaction with the exocytotic process. It is proposed that these effects are mediated by a pertussis toxin-sensitive GTP-binding protein.

UR - http://www.scopus.com/inward/record.url?scp=0024545078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024545078&partnerID=8YFLogxK

M3 - Article

C2 - 2463254

AN - SCOPUS:0024545078

VL - 264

SP - 973

EP - 980

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -